메뉴 건너뛰기




Volumn 32, Issue SUPPL. 1, 2010, Pages

Therapeutical use of the cannabinoids in psychiatry;Uso terapêutico dos canabinoides em psiquiatria

Author keywords

Cannabidiol; Cannabinoids; Psychiatry; Tetrahydrocannabinol; Therapeutic uses

Indexed keywords

CANNABIDIOL; PIPERIDINE DERIVATIVE; PSYCHOTROPIC AGENT; PYRAZOLE DERIVATIVE; RIMONABANT; TETRAHYDROCANNABINOL;

EID: 78650597507     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (52)

References (99)
  • 1
    • 33746139659 scopus 로고    scopus 로고
    • History of cannabis as a medicine: A review
    • Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006;28(2):153-7
    • (2006) Rev Bras Psiquiatr , vol.28 , Issue.2 , pp. 153-157
    • Zuardi, A.W.1
  • 2
    • 0002454039 scopus 로고
    • Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp
    • Adams R, Hunt M, Clark JH. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. J Am Chem Soc. 1940;62:196-200
    • (1940) J Am Chem Soc , vol.62 , pp. 196-200
    • Adams, R.1    Hunt, M.2    Clark, J.H.3
  • 4
    • 28844489930 scopus 로고    scopus 로고
    • A tale of two cannabinoids: The therapeutic rationale forcombining tetrahydrocannabinol and cannabidiol
    • Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale forcombining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66(2):234-46
    • (2006) Med Hypotheses , vol.66 , Issue.2 , pp. 234-246
    • Russo, E.1    Guy, G.W.2
  • 5
    • 0033538561 scopus 로고    scopus 로고
    • Discovery and characterization of endogenous cannabinoids
    • Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sci. 1999; 65(6-7):573-95
    • (1999) Life Sci , vol.65 , Issue.6-7 , pp. 573-595
    • Martin, B.R.1    Mechoulam, R.2    Razdan, R.K.3
  • 6
    • 79952198851 scopus 로고    scopus 로고
    • Endocannabinoids and psychiatric disorders - the road ahead
    • Mechoulam R. Endocannabinoids and psychiatric disorders - the road ahead. Rev Bras Psiquiatr. 2010;32(Suppl I):S5-6
    • (2010) Rev Bras Psiquiatr , vol.32 , Issue.SUPPL. I
    • Mechoulam, R.1
  • 7
    • 43749091232 scopus 로고    scopus 로고
    • Cannabis and psychiatric disorders: It is not only addiction
    • Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol. 2008;13(2):264-75
    • (2008) Addict Biol , vol.13 , Issue.2 , pp. 264-275
    • Leweke, F.M.1    Koethe, D.2
  • 9
    • 0020079139 scopus 로고
    • Action of cannabidiol on the anxiety and other effects produced by D9-THC in normal subjects
    • Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG. Action of cannabidiol on the anxiety and other effects produced by D9-THC in normal subjects. Psychopharmacology (Berl). 1982;76(3):245-50
    • (1982) Psychopharmacology (Berl) , vol.76 , Issue.3 , pp. 245-250
    • Zuardi, A.W.1    Shirakawa, I.2    Finkelfarb, E.3    Karniol, I.G.4
  • 10
    • 0019771429 scopus 로고
    • Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior
    • Silveira Filho NG, Tufik S. Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior. Res Commun Psychol Psychiatry Behav. 1981;6:25-6
    • (1981) Res Commun Psychol Psychiatry Behav , vol.6 , pp. 25-26
    • Silveira, F.N.G.1    Tufik, S.2
  • 11
    • 0842282227 scopus 로고
    • Changes in the conditioned emotional response of rats induced by D9-THC, CBD and mixture of the two cannabinoids
    • Zuardi AW, Karniol IG. Changes in the conditioned emotional response of rats induced by D9-THC, CBD and mixture of the two cannabinoids. Arq Biol Tecnol. 1983;26:391-7
    • (1983) Arq Biol Tecnol , vol.26 , pp. 391-397
    • Zuardi, A.W.1    Karniol, I.G.2
  • 14
    • 33746647403 scopus 로고    scopus 로고
    • Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats
    • Resstel LB, Joca SR, Moreira FA, Corrêa FM, Guimarães FS. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res. 2006;172(2):294-8
    • (2006) Behav Brain Res , vol.172 , Issue.2 , pp. 294-298
    • Resstel, L.B.1    Joca, S.R.2    Moreira, F.A.3    Corrêa, F.M.4    Guimarães, F.S.5
  • 15
    • 65549106424 scopus 로고    scopus 로고
    • 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
    • Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol. 2009;156(1):181-8
    • (2009) Br J Pharmacol , vol.156 , Issue.1 , pp. 181-188
    • Resstel, L.B.1    Tavares, R.F.2    Lisboa, S.F.3    Joca, S.R.4    Corrêa, F.M.5    Guimarães, F.S.6
  • 16
    • 53649087673 scopus 로고    scopus 로고
    • Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats
    • Bitencourt RM, Pamplona FA, Takahashi RN. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 2008;18(12):849-59
    • (2008) Eur Neuropsychopharmacol , vol.18 , Issue.12 , pp. 849-859
    • Bitencourt, R.M.1    Pamplona, F.A.2    Takahashi, R.N.3
  • 17
    • 0025331052 scopus 로고
    • Pharmacological characterization of cannabinoids in the elevated plus maze
    • Onaivi ES, Green MR, Martin BR. Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther. 1990;253(3):1002-9
    • (1990) J Pharmacol Exp Ther , vol.253 , Issue.3 , pp. 1002-1009
    • Onaivi, E.S.1    Green, M.R.2    Martin, B.R.3
  • 18
    • 71549171421 scopus 로고    scopus 로고
    • Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
    • Campos AC, Guimarães FS. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1517-21
    • (2009) Prog Neuropsychopharmacol Biol Psychiatry , vol.33 , Issue.8 , pp. 1517-1521
    • Campos, A.C.1    Guimarães, F.S.2
  • 19
    • 46649094780 scopus 로고    scopus 로고
    • Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
    • Moreira FA, Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl). 2008;199(2):223-30
    • (2008) Psychopharmacology (Berl) , vol.199 , Issue.2 , pp. 223-230
    • Moreira, F.A.1    Campos, A.C.2    Guimarães, F.S.3
  • 21
    • 67649274432 scopus 로고    scopus 로고
    • Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats
    • Malone DT, Jongejan D, Taylor DA. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Pharmacol Biochem Behav. 2009;93(2):91-6
    • (2009) Pharmacol Biochem Behav , vol.93 , Issue.2 , pp. 91-96
    • Malone, D.T.1    Jongejan, D.2    Taylor, D.A.3
  • 23
    • 46649094780 scopus 로고    scopus 로고
    • Involvement of 5HT1A receptors in the anxiolyticlike effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
    • Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolyticlike effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl). 2008;199(2):223-30
    • (2008) Psychopharmacology (Berl) , vol.199 , Issue.2 , pp. 223-230
    • Campos, A.C.1    Guimarães, F.S.2
  • 26
    • 77950537848 scopus 로고    scopus 로고
    • National Science and Technology Institute for Translational Medicine (INCT-TM): Advancing the field of translational medicine and mental health
    • Hallak JE, Crippa JA, Quevedo J, Roesler R, Schröder N, Nardi AE, Kapczinski F. National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health. Rev Bras Psiquiatr. 2010;32(1):85-90
    • (2010) Rev Bras Psiquiatr , vol.32 , Issue.1 , pp. 85-90
    • Hallak, J.E.1    Crippa, J.A.2    Quevedo, J.3    Roesler, R.4    Schröder, N.5    Nardi, A.E.6    Kapczinski, F.7
  • 31
    • 77957236596 scopus 로고    scopus 로고
    • The effect of cannabidiol (CBD), a cannabis sativa constituent, on neural correlates of anxiety: A regional cerebral blood flow study
    • 12th International Congress on Schizophrenia Research; San Diego, Mar 28-Apr 01
    • Crippa JA, Derenusson G, Zuardi AW, Wichert-Ana L, Duran F, Ferrari TB, Martin-Santos R, McGuire PK, Busatto GF, Hallak JE. The effect of cannabidiol (CBD), a cannabis sativa constituent, on neural correlates of anxiety: a regional cerebral blood flow study. Schizophrenia Bulletin; 12th International Congress on Schizophrenia Research; San Diego, Mar 28-Apr 01, 2009;35(Suppl 1):197-198
    • (2009) Schizophrenia Bulletin , vol.35 , Issue.SUPPL. 1 , pp. 197-198
    • Crippa, J.A.1    Derenusson, G.2    Zuardi, A.W.3    Wichert-Ana, L.4    Duran, F.5    Ferrari, T.B.6    Martin-Santos, R.7    McGuire, P.K.8    Busatto, G.F.9    Hallak, J.E.10
  • 32
    • 41049117284 scopus 로고    scopus 로고
    • Magnetic resonance spectroscopy in anxiety disorders
    • Trzesniak C, Araújo D, Crippa JA. Magnetic resonance spectroscopy in anxiety disorders. Acta Neuropsychiatrica. 2008;20(2):56-71
    • (2008) Acta Neuropsychiatrica , vol.20 , Issue.2 , pp. 56-71
    • Trzesniak, C.1    Araújo, D.2    Crippa, J.A.3
  • 33
    • 54249123588 scopus 로고    scopus 로고
    • Structural magnetic resonance imaging in anxiety disorders: An update of research findings
    • Ferrari MC, Busatto GF, McGuire PK, Crippa JA. Structural magnetic resonance imaging in anxiety disorders: an update of research findings. Rev Bras Psiquiatr. 2008;30(3):251-64
    • (2008) Rev Bras Psiquiatr , vol.30 , Issue.3 , pp. 251-264
    • Ferrari, M.C.1    Busatto, G.F.2    McGuire, P.K.3    Crippa, J.A.4
  • 34
    • 0025876938 scopus 로고
    • Effects of cannabidiol in animal models predictive of antipsychotic activity
    • Zuardi AW, Rodrigues JA, Cunha JM. Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology (Berl). 1991;104(2):260-4
    • (1991) Psychopharmacology (Berl) , vol.104 , Issue.2 , pp. 260-264
    • Zuardi, A.W.1    Rodrigues, J.A.2    Cunha, J.M.3
  • 35
    • 17444393586 scopus 로고    scopus 로고
    • Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
    • Moreira FA, Guimarães FS. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol. 2005;512(2- 3):199-205
    • (2005) Eur J Pharmacol , vol.512 , Issue.2-3 , pp. 199-205
    • Moreira, F.A.1    Guimarães, F.S.2
  • 36
    • 2442641276 scopus 로고    scopus 로고
    • Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum
    • Guimarães VM, Zuardi AW, Del Bel EA, Guimarães FS. Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum. Life Sci. 2004;75(5):633-8
    • (2004) Life Sci , vol.75 , Issue.5 , pp. 633-638
    • Guimarães, V.M.1    Zuardi, A.W.2    Del Bel, E.A.3    Guimarães, F.S.4
  • 37
    • 84876182471 scopus 로고    scopus 로고
    • Different effec os cannabinoids: Relevance to psychosis and schizophrenia
    • Leweke FM, Schneider U, Radwan M, Schmidt E, Emrich M. Different effec os cannabinoids: relevance to psychosis and schizophrenia. Rev Bras Psiquiatr. 2010;32(Suppl I):S15-30
    • (2010) Rev Bras Psiquiatr , vol.32 , Issue.SUPPL. I
    • Leweke, F.M.1    Schneider, U.2    Radwan, M.3    Schmidt, E.4    Emrich, M.5
  • 41
    • 43749124214 scopus 로고    scopus 로고
    • Effects of cannabidiol on schizophrenialike symptoms in people who use cannabis
    • Morgan CJ, Curran HV. Effects of cannabidiol on schizophrenialike symptoms in people who use cannabis. Br J Psychiatry. 2008;192(4):306-7
    • (2008) Br J Psychiatry , vol.192 , Issue.4 , pp. 306-307
    • Morgan, C.J.1    Curran, H.V.2
  • 42
    • 46949099370 scopus 로고    scopus 로고
    • Cannabis and schizophrenia: Towards a cannabinoid hypothesis of schizophrenia
    • Müller-Vahl KR, Emrich HM. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert Rev Neurother. 2008;8(7):1037-48
    • (2008) Expert Rev Neurother , vol.8 , Issue.7 , pp. 1037-1048
    • Müller-Vahl, K.R.1    Emrich, H.M.2
  • 48
    • 0029927520 scopus 로고    scopus 로고
    • Psychotic symptoms in Parkinson's disease patients with dementia
    • Naimark D, Jackson E, Rockwell E, Jeste DV. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc. 1996;44(3):296-9
    • (1996) J Am Geriatr Soc , vol.44 , Issue.3 , pp. 296-299
    • Naimark, D.1    Jackson, E.2    Rockwell, E.3    Jeste, D.V.4
  • 49
    • 27144556090 scopus 로고    scopus 로고
    • Psychosis in Parkinson's disease
    • Thanvi BR, Lo TC, Harsh DP. Psychosis in Parkinson's disease. Postgrad Med J. 2005;81(960):644-6
    • (2005) Postgrad Med J , vol.81 , Issue.960 , pp. 644-646
    • Thanvi, B.R.1    Lo, T.C.2    Harsh, D.P.3
  • 51
    • 0015817954 scopus 로고
    • Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol
    • Karniol IG, Carlini EA. Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol. Psychopharmacologia. 1973;33(1):53-70
    • (1973) Psychopharmacologia , vol.33 , Issue.1 , pp. 53-70
    • Karniol, I.G.1    Carlini, E.A.2
  • 52
    • 0016198967 scopus 로고
    • Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior
    • Davis WM, Borgen LA. Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol. 1974;9(3): 453-62
    • (1974) Res Commun Chem Pathol Pharmacol , vol.9 , Issue.3 , pp. 453-462
    • Davis, W.M.1    Borgen, L.A.2
  • 53
    • 0017652749 scopus 로고
    • Hypnoticlike effects of cannabidiol in the rat
    • Monti JM. Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology (Berl). 1977;55(3):263-5
    • (1977) Psychopharmacology (Berl) , vol.55 , Issue.3 , pp. 263-265
    • Monti, J.M.1
  • 54
    • 0019604414 scopus 로고
    • Hypnotic and antiepileptic effects of cannabidiol
    • Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21(8-9 Suppl):417S-27S.
    • (1981) J Clin Pharmacol , vol.21 , Issue.8-9 SUPPL.
    • Carlini, E.A.1    Cunha, J.M.2
  • 56
    • 0027263719 scopus 로고
    • Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers
    • Zuardi AW, Guimarães FS, Moreira AC. Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res. 1993;26(2):213-7
    • (1993) Braz J Med Biol Res , vol.26 , Issue.2 , pp. 213-217
    • Zuardi, A.W.1    Guimarães, F.S.2    Moreira, A.C.3
  • 57
    • 54249156391 scopus 로고    scopus 로고
    • Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action
    • Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr. 2008;30(3):271-80
    • (2008) Rev Bras Psiquiatr , vol.30 , Issue.3 , pp. 271-280
    • Zuardi, A.W.1
  • 59
    • 70349189518 scopus 로고    scopus 로고
    • Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb
    • Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30(10):515-27
    • (2009) Trends Pharmacol Sci , vol.30 , Issue.10 , pp. 515-527
    • Izzo, A.A.1    Borrelli, F.2    Capasso, R.3    Di Marzo, V.4    Mechoulam, R.5
  • 60
    • 74549165354 scopus 로고    scopus 로고
    • Antidepressantlike effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
    • Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR. Antidepressantlike effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 2010;159(1):122-8
    • (2010) Br J Pharmacol , vol.159 , Issue.1 , pp. 122-128
    • Zanelati, T.V.1    Biojone, C.2    Moreira, F.A.3    Guimarães, F.S.4    Joca, S.R.5
  • 61
    • 0015656165 scopus 로고
    • Cannabidiol and cannabis sativa extract protect mice and rats against convulsive agents
    • Carlini EA, Leite JR, Tanhauser M, Berardi AC. Cannabidiol and cannabis sativa extract protect mice and rats against convulsive agents. J Pharm Pharmacol. 1973;25(8):664-5
    • (1973) J Pharm Pharmacol , vol.25 , Issue.8 , pp. 664-665
    • Carlini, E.A.1    Leite, J.R.2    Tanhauser, M.3    Berardi, A.C.4
  • 62
    • 0015543610 scopus 로고
    • Effect of cannabidiol and other Cannabis sativa compounds on hippocampal seizures discharges
    • Izquierdo I, Orsingher OA, Berardi AC. Effect of cannabidiol and other Cannabis sativa compounds on hippocampal seizures discharges. Psychopharmacologia. 1973;28(1):95-102
    • (1973) Psychopharmacologia , vol.28 , Issue.1 , pp. 95-102
    • Izquierdo, I.1    Orsingher, O.A.2    Berardi, A.C.3
  • 64
    • 18844381146 scopus 로고    scopus 로고
    • Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential
    • Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. J Psychopharmacol. 2005;19(3):293-300
    • (2005) J Psychopharmacol , vol.19 , Issue.3 , pp. 293-300
    • Ashton, C.H.1    Moore, P.B.2    Gallagher, P.3    Young, A.H.4
  • 67
    • 79952196961 scopus 로고    scopus 로고
    • Pharmacological and Psychosocial Interventions for Cannabis Use Disorders
    • In press
    • Budney AJ, Vandrey RG, Stanger C. Pharmacological and Psychosocial Interventions for Cannabis Use Disorders. Rev Bras Psiquiatr. In press 2010
    • (2010) Rev Bras Psiquiatr
    • Budney, A.J.1    Vandrey, R.G.2    Stanger, C.3
  • 68
    • 67649400461 scopus 로고    scopus 로고
    • Pharmacotherapy for cannabis dependence: How close are we?
    • Vandrey R, Haney M. Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs. 2009;23(7):543-53
    • (2009) CNS Drugs , vol.23 , Issue.7 , pp. 543-553
    • Vandrey, R.1    Haney, M.2
  • 69
    • 72449197981 scopus 로고    scopus 로고
    • Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances
    • Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 2009; 29(47):14764-9
    • (2009) J Neurosci , vol.29 , Issue.47 , pp. 14764-14769
    • Ren, Y.1    Whittard, J.2    Higuera-Matas, A.3    Morris, C.V.4    Hurd, Y.L.5
  • 70
    • 0034792214 scopus 로고    scopus 로고
    • Marijuana abstinence effects in marijuana smokers maintained in their home environment
    • Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry. 2001;58(10):917-24
    • (2001) Arch Gen Psychiatry , vol.58 , Issue.10 , pp. 917-924
    • Budney, A.J.1    Hughes, J.R.2    Moore, B.A.3    Novy, P.L.4
  • 71
    • 0032776569 scopus 로고    scopus 로고
    • Substance use among young people: The relationship between perceived functions and intentions
    • Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance use among young people: the relationship between perceived functions and intentions. Addiction. 1999;94(7):1043-50
    • (1999) Addiction , vol.94 , Issue.7 , pp. 1043-1050
    • Boys, A.1    Marsden, J.2    Griffiths, P.3    Fountain, J.4    Stillwell, G.5    Strang, J.6
  • 72
    • 0019604393 scopus 로고
    • The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety
    • Fabre LF, McLendon D. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J Clin Pharmacol. 1981;21(8-9 Suppl):377S-382S.
    • (1981) J Clin Pharmacol , vol.21 , Issue.8-9 SUPPL
    • Fabre, L.F.1    McLendon, D.2
  • 73
    • 0019415351 scopus 로고
    • Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis
    • Ilaria RL, Thornby JI, Fann WE. Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis. Curr Ther Res. 1981;29:943-9
    • (1981) Curr Ther Res , vol.29 , pp. 943-949
    • Ilaria, R.L.1    Thornby, J.I.2    Fann, W.E.3
  • 74
    • 26044436588 scopus 로고    scopus 로고
    • Neurophysiological and subjective profile of marihuana with varying concentrations of cannabinoids
    • Ilan AB, Gevins A, Coleman M, Elsohly MA, de Wit H. Neurophysiological and subjective profile of marihuana with varying concentrations of cannabinoids. Behav Pharmacol. 2005;16(5-6):487-96
    • (2005) Behav Pharmacol , vol.16 , Issue.5-6 , pp. 487-496
    • Ilan, A.B.1    Gevins, A.2    Coleman, M.3    Elsohly, M.A.4    de Wit, H.5
  • 75
    • 4043096916 scopus 로고    scopus 로고
    • Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial
    • Svendson KB, Troels SJ, Fleming WB. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial. BMJ. 2004;329(7460): 253-7
    • (2004) BMJ , vol.329 , Issue.7460 , pp. 253-257
    • Svendson, K.B.1    Troels, S.J.2    Fleming, W.B.3
  • 77
    • 79851503776 scopus 로고    scopus 로고
    • Behavioral cognitive and psychophysiological effects os cannabinoids: Relevance to psychosis and schizophrenia
    • Sewell RA, Skosnik PD, Garcia-Sosa I, Ranganathan M, D'Souza DC. Behavioral cognitive and psychophysiological effects os cannabinoids: relevance to psychosis and schizophrenia. Rev Bras Psiquiatr. 2010;32(Suppl I):S15-30
    • (2010) Rev Bras Psiquiatr , vol.32 , Issue.SUPPL. I
    • Sewell, R.A.1    Skosnik, P.D.2    Garcia-Sosa, I.3    Ranganathan, M.4    D'souza, D.C.5
  • 78
    • 67649265233 scopus 로고    scopus 로고
    • Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia
    • Schwarcz G, Karajgi B, McCarthy R. Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. J Clin Psychopharmacol. 2009;29(3):255-8
    • (2009) J Clin Psychopharmacol , vol.29 , Issue.3 , pp. 255-258
    • Schwarcz, G.1    Karajgi, B.2    McCarthy, R.3
  • 80
    • 41949083220 scopus 로고    scopus 로고
    • Use of dronabinol for cannabis dependence: Two case reports and review
    • Levin FR, Kleber HD. Use of dronabinol for cannabis dependence: two case reports and review. Am J Addict. 2008;17(2):161-4
    • (2008) Am J Addict , vol.17 , Issue.2 , pp. 161-164
    • Levin, F.R.1    Kleber, H.D.2
  • 82
    • 0015757749 scopus 로고
    • (-) Delta 9 THC as an hypnotic. An experimental study of three dose levels
    • Cousens K, DiMascio A. (-) Delta 9 THC as an hypnotic. An experimental study of three dose levels. Psychopharmacologia. 1973;33(4):355-64
    • (1973) Psychopharmacologia , vol.33 , Issue.4 , pp. 355-364
    • Cousens, K.1    Dimascio, A.2
  • 83
    • 76249123626 scopus 로고    scopus 로고
    • The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial
    • Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010;110(2):604-10
    • (2010) Anesth Analg , vol.110 , Issue.2 , pp. 604-610
    • Ware, M.A.1    Fitzcharles, M.A.2    Joseph, L.3    Shir, Y.4
  • 84
    • 0031855913 scopus 로고    scopus 로고
    • The use of cannabis as a mood stabilizer in bipolar disorder: Anecdotal evidence and the need for clinical research
    • Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoactive Drugs. 1998;30(2):171-7
    • (1998) J Psychoactive Drugs , vol.30 , Issue.2 , pp. 171-177
    • Grinspoon, L.1    Bakalar, J.B.2
  • 85
    • 67650504086 scopus 로고    scopus 로고
    • The psychiatric side-effects of rimonabant
    • Moreira FA, Crippa JA. The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr. 2009;31(2):145-53
    • (2009) Rev Bras Psiquiatr , vol.31 , Issue.2 , pp. 145-153
    • Moreira, F.A.1    Crippa, J.A.2
  • 87
    • 33344467124 scopus 로고    scopus 로고
    • The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers
    • Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Huestis MA. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J. 2006;151(3):754.e1-754.e5
    • (2006) Am Heart J , vol.151 , Issue.3
    • Gorelick, D.A.1    Heishman, S.J.2    Preston, K.L.3    Nelson, R.A.4    Moolchan, E.T.5    Huestis, M.A.6
  • 91
    • 4444376204 scopus 로고    scopus 로고
    • Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats
    • Colombo G, Vacca G, Serra S, Carai MA, Gessa GL. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. Eur J Pharmacol. 2004;498(1-3):119-23
    • (2004) Eur J Pharmacol , vol.498 , Issue.1-3 , pp. 119-123
    • Colombo, G.1    Vacca, G.2    Serra, S.3    Carai, M.A.4    Gessa, G.L.5
  • 92
    • 0036748948 scopus 로고    scopus 로고
    • SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
    • Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol. 2002;13(5-6):451-63
    • (2002) Behav Pharmacol , vol.13 , Issue.5-6 , pp. 451-463
    • Cohen, C.1    Perrault, G.2    Voltz, C.3    Steinberg, R.4    Soubrié, P.5
  • 93
    • 58349105218 scopus 로고    scopus 로고
    • A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: Efficacy, safety and weight gain
    • CIRRUS Study Group
    • Rigotti NA, Gonzales D, Dale LC, Lawrence D, Chang Y; CIRRUS Study Group. A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain. Addiction. 2009;104(2):266-76
    • (2009) Addiction , vol.104 , Issue.2 , pp. 266-276
    • Rigotti, N.A.1    Gonzales, D.2    Dale, L.C.3    Lawrence, D.4    Chang, Y.5
  • 94
    • 58349117493 scopus 로고    scopus 로고
    • Trial comes too late as psychiatric side effects end hope for rimonabant
    • Stapleton JA. Trial comes too late as psychiatric side effects end hope for rimonabant. Addiction. 2009;104(2):277-8
    • (2009) Addiction , vol.104 , Issue.2 , pp. 277-278
    • Stapleton, J.A.1
  • 95
    • 0033059089 scopus 로고    scopus 로고
    • Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils
    • Poncelet M, Barnouin MC, Brelière JC, Le Fur G, Soubrié P. Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils. Psychopharmacology (Berl). 1999;144(2):144-50
    • (1999) Psychopharmacology (Berl) , vol.144 , Issue.2 , pp. 144-150
    • Poncelet, M.1    Barnouin, M.C.2    Brelière, J.C.3    Le Fur, G.4    Soubrié, P.5
  • 96
    • 2942538034 scopus 로고    scopus 로고
    • Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder
    • Meta-Trial Study Group
    • Meltzer HY, Arvanitis L, Bauer D, Rein W; Meta-Trial Study Group. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry. 2004;161(6):975-84
    • (2004) Am J Psychiatry , vol.161 , Issue.6 , pp. 975-984
    • Meltzer, H.Y.1    Arvanitis, L.2    Bauer, D.3    Rein, W.4
  • 98
    • 0030456030 scopus 로고    scopus 로고
    • Do patients use marijuana as an antidepressant?
    • Gruber AJ, Pope HG, Brown ME. Do patients use marijuana as an antidepressant? Depression. 1996;4:77-80
    • (1996) Depression , vol.4 , pp. 77-80
    • Gruber, A.J.1    Pope, H.G.2    Brown, M.E.3
  • 99
    • 69249116618 scopus 로고    scopus 로고
    • Imaging the neural effects of cannabinoids: Current status and future opportunities for psychopharmacology
    • Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar- Poli P. Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des. 2009;15(22):2603-14.
    • (2009) Curr Pharm Des , vol.15 , Issue.22 , pp. 2603-2614
    • Bhattacharyya, S.1    Crippa, J.A.2    Martin-Santos, R.3    Winton-Brown, T.4    Fusar-Poli, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.